Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Mar;79(7-8):1074–1084. doi: 10.1038/sj.bjc.6690172

In vitro radiosensitivity of tumour cells and fibroblasts derived from head and neck carcinomas: mutual relationship and correlation with clinical data

B Stausbøl-Grøn 1, S M Bentzen 1, K E Jørgensen 2, O S Nielsen 3, T Bundgaard 4, J Overgaard 1,3
PMCID: PMC2362224  PMID: 10098739

Abstract

The aim was to characterize the variation in the cellular in vitro radiosensitivities in squamous cell carcinomas of the head and neck, and to test for a possible correlation between different measures of radiosensitivity and the clinical and histopathological data. Cellular in vitro radiosensitivities were assessed in tumour biopsies from 71 patients using the modified Courtenay–Mills soft agar clonogenic assay combined with an immunocytochemical analysis. Radiosensitivity was quantified as the surviving fraction after a radiation dose of 2 Gy irrespective of cell type (overall SF2), or based on identification of cell type (tumour cell SF2, fibroblast SF2). Sixty-three biopsies were from primary tumours, and eight were from recurrences. Overall plating efficiency ranged from 0.005 to 1.60% with a median of 0.052%. The majority of the colonies obtained from the biopsies were fibroblast marker-positive; the proportion of tumour marker-positive colonies ranged from 1 to 88% with a median of 15%. The median overall SF2 was 0.47 (range 0.24–0.96), the median tumour cell SF2 was 0.50 (range 0.11–1.0) and the median fibroblast SF2 was 0.49 (range 0.24–1.0). Comparing data from independent experiments, the overall SF2 was significantly correlated with the SF2 of fibroblasts (2P = 0.006) but not with the tumour cell SF2. The tumour cell and fibroblast radiosensitivities measured in the same individuals were not correlated (r = 0.06, 95% CI [–0.19, 0.30]). This finding seems to preclude a strong correlation between the radiosensitivity of tumour cells and fibroblasts. Concerning the clinical characteristics, neither of the measures of tumour radiosensitivity was correlated with T- and N-category, stage, tumour size, sex and age. However, the tumour cell radiosensitivity decreased with increasing grade of histopathological differentiation (2P = 0.012). The same tendency was found in two independent analyses of the same patient material. This correlation was not significant in case of the overall SF2 or the fibroblast SF2. © 1999 Cancer Research Campaign

Keywords: predictive assays, in vitro radiosensitivity, squamous cell carcinoma of the head and neck, differentiation, fibroblasts, tumour cells

Full Text

The Full Text of this article is available as a PDF (639.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azumi N., Battifora H. The distribution of vimentin and keratin in epithelial and nonepithelial neoplasms. A comprehensive immunohistochemical study on formalin- and alcohol-fixed tumors. Am J Clin Pathol. 1987 Sep;88(3):286–296. doi: 10.1093/ajcp/88.3.286. [DOI] [PubMed] [Google Scholar]
  2. Beck-Bornholdt H. P., Dubben H. H. Potential pitfalls in the use of p-values and in interpretation of significance levels. Radiother Oncol. 1994 Nov;33(2):171–176. doi: 10.1016/0167-8140(94)90072-8. [DOI] [PubMed] [Google Scholar]
  3. Bentzen S. M. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother Oncol. 1997 May;43(2):121–131. doi: 10.1016/s0167-8140(97)01899-9. [DOI] [PubMed] [Google Scholar]
  4. Bernier J., Thames H. D., Smith C. D., Horiot J. C. Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy. Radiother Oncol. 1998 May;47(2):137–143. doi: 10.1016/s0167-8140(97)00221-1. [DOI] [PubMed] [Google Scholar]
  5. Brock W. A., Baker F. L., Peters L. J. Radiosensitivity of human head and neck squamous cell carcinomas in primary culture and its potential as a predictive assay of tumor radiocurability. Int J Radiat Biol. 1989 Nov;56(5):751–760. doi: 10.1080/09553008914552001. [DOI] [PubMed] [Google Scholar]
  6. Brock W. A., Baker F. L., Wike J. L., Sivon S. L., Peters L. J. Cellular radiosensitivity of primary head and neck squamous cell carcinomas and local tumor control. Int J Radiat Oncol Biol Phys. 1990 Jun;18(6):1283–1286. doi: 10.1016/0360-3016(90)90298-x. [DOI] [PubMed] [Google Scholar]
  7. Dahl O., Horn A., Mella O. Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol. 1994;33(4):409–413. doi: 10.3109/02841869409098437. [DOI] [PubMed] [Google Scholar]
  8. Dahlberg W. K., Little J. B., Fletcher J. A., Suit H. D., Okunieff P. Radiosensitivity in vitro of human soft tissue sarcoma cell lines and skin fibroblasts derived from the same patients. Int J Radiat Biol. 1993 Feb;63(2):191–198. doi: 10.1080/09553009314550251. [DOI] [PubMed] [Google Scholar]
  9. Davidson S. E., West C. M., Roberts S. A., Hendry J. H., Hunter R. D. Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol. 1990 Aug;18(4):349–356. doi: 10.1016/0167-8140(90)90115-d. [DOI] [PubMed] [Google Scholar]
  10. Deacon J., Peckham M. J., Steel G. G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother Oncol. 1984 Dec;2(4):317–323. doi: 10.1016/s0167-8140(84)80074-2. [DOI] [PubMed] [Google Scholar]
  11. Dische S., Saunders M., Barrett A., Harvey A., Gibson D., Parmar M. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol. 1997 Aug;44(2):123–136. doi: 10.1016/s0167-8140(97)00094-7. [DOI] [PubMed] [Google Scholar]
  12. Fertil B., Malaise E. P. Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy. Int J Radiat Oncol Biol Phys. 1981 May;7(5):621–629. doi: 10.1016/0360-3016(81)90377-1. [DOI] [PubMed] [Google Scholar]
  13. Fertil B., Malaise E. P. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys. 1985 Sep;11(9):1699–1707. doi: 10.1016/0360-3016(85)90223-8. [DOI] [PubMed] [Google Scholar]
  14. Geara F. B., Peters L. J., Ang K. K., Garden A. S., Tucker S. L., Levy L. B., Brown B. W. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy. Int J Radiat Oncol Biol Phys. 1996 Jun 1;35(3):455–462. doi: 10.1016/s0360-3016(96)80006-x. [DOI] [PubMed] [Google Scholar]
  15. Girinsky T., Bernheim A., Lubin R., Tavakoli-Razavi T., Baker F., Janot F., Wibault P., Cosset J. M., Duvillard P., Duverger A. In vitro parameters and treatment outcome in head and neck cancers treated with surgery and/or radiation: cell characterization and correlations with local control and overall survival. Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):789–794. doi: 10.1016/0360-3016(94)90350-6. [DOI] [PubMed] [Google Scholar]
  16. Haustermans K., Hofland I., Ramaekers M., Ivanyi D., Balm A. J., Geboes K., Lerut T., van der Schueren E., Begg A. C. Enrichment of tumor cells for cell kinetic analysis in human tumor biopsies using cytokeratin gating. Radiother Oncol. 1996 Dec;41(3):237–248. doi: 10.1016/s0167-8140(96)01846-4. [DOI] [PubMed] [Google Scholar]
  17. Peters L. J., Brock W. A., Chapman J. D., Wilson G. Predictive assays of tumor radiocurability. Am J Clin Oncol. 1988 Jun;11(3):275–287. doi: 10.1097/00000421-198806000-00005. [DOI] [PubMed] [Google Scholar]
  18. Stausbøl-Grøn B., Bentzen S. M., Overgaard J. Characterization and radiosensitivity of fibroblasts derived from squamous cell carcinomas of the head and neck, and the surrounding oral mucosa. Acta Oncol. 1998;37(7-8):697–700. doi: 10.1080/028418698430070. [DOI] [PubMed] [Google Scholar]
  19. Suo Z., Holm R., Nesland J. M. Squamous cell carcinomas, an immunohistochemical and ultrastructural study. Anticancer Res. 1992 Nov-Dec;12(6B):2025–2031. [PubMed] [Google Scholar]
  20. Tucker S. L., Turesson I., Thames H. D. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer. 1992;28A(11):1783–1791. doi: 10.1016/0959-8049(92)90004-l. [DOI] [PubMed] [Google Scholar]
  21. West C. M., Davidson S. E., Hunter R. D. Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int J Radiat Biol. 1989 Nov;56(5):761–765. doi: 10.1080/09553008914552011. [DOI] [PubMed] [Google Scholar]
  22. West C. M., Davidson S. E., Roberts S. A., Hunter R. D. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer. 1993 Oct;68(4):819–823. doi: 10.1038/bjc.1993.434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. West C. M., Davidson S. E., Roberts S. A., Hunter R. D. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer. 1997;76(9):1184–1190. doi: 10.1038/bjc.1997.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. West C. M. Invited review: intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br J Radiol. 1995 Aug;68(812):827–837. doi: 10.1259/0007-1285-68-812-827. [DOI] [PubMed] [Google Scholar]
  25. West C. M., Sutherland R. M. A radiobiological comparison of human tumor soft-agar clonogenic assays. Int J Cancer. 1986 Jun 15;37(6):897–903. doi: 10.1002/ijc.2910370616. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES